Friday, January 25, 2013

• It's All Relative for This Biotech Underperformerat Motley Fool (Fri, Jan 25)
• Morgan Stanley Adviser Dowd Charged With Pharmasset Tipsat Bloomberg (Fri, Jan 25)
• TRC makes mini offer for First Solar sharesAP (Fri, Jan 25)
• Gilead's HIV Candidate AdvancesZacks (Fri, Jan 25)
• Pharmasset Deal Leads to Insider Charge Against Floridianat Bloomberg (Fri, Jan 25)
• Dover Weakness Seen as Overdone and 4 Stock Analyses Attracting Attentionat Wall St. Cheat Sheet (Fri, Jan 25)
• Gilead Sciences Inc Stock Buy Recommendation Reiterated (GILD)at TheStreet (Fri, Jan 25)

Thursday, January 24, 2013

• Gilead Reaches New 52-Week High (GILD)at TheStreet (Thu, Jan 24)
• Gilead Initiates Phase 3 Clinical Program for Tenofovir Alafenamide, a Novel Low-Dose Prodrug for the Treatment of HIVBusiness Wire (Thu, Jan 24)

Wednesday, January 23, 2013

• Foolish Preview: Bristol-Myers Squibbat Motley Fool (Wed, Jan 23)
• Gilead Sciences Inc (GILD): Today's Featured Drugs Laggardat TheStreet (Wed, Jan 23)
• Celgene Earnings: What To Watch Forat Seeking Alpha (Wed, Jan 23)
• 4 Merger and Acquisitions Stock Stories for Investor Pleasureat Wall St. Cheat Sheet (Wed, Jan 23)

Tuesday, January 22, 2013

• Get Your Large Growers Hereat Motley Fool (Tue, Jan 22)
• Potential Takeover Targets: Morgan Stanley Reportat CNBC (Tue, Jan 22)

Monday, January 21, 2013

• Why You Should Sell Vertexat Seeking Alpha (Mon, Jan 21)

Saturday, January 19, 2013

• Monsanto to Address EPA Concerns and 4 Stocks Rising to 52-Week Highsat Wall St. Cheat Sheet (Sat, Jan 19)

Friday, January 18, 2013

• Stocks for MLK Dayat Motley Fool (Fri, Jan 18)
• YM Biosciences says ISS, Glass Lewis endorse Gilead dealat theflyonthewall.com (Fri, Jan 18)

Wednesday, January 16, 2013

• [video] Am I Diversified? Cramer's Call!at CNBC (Wed, Jan 16)
• What Color Is Your Patent Cliff Parachute?at Motley Fool (Wed, Jan 16)
• The Smart Money Loves These 10 Stocksat Seeking Alpha (Wed, Jan 16)

Tuesday, January 15, 2013

• 3 Reasons to Buy Celgeneat Motley Fool (Tue, Jan 15)
• Gilead Sciences Inc Stock Buy Recommendation Reiterated (GILD)at TheStreet (Tue, Jan 15)

Monday, January 14, 2013

• Is This the Softer Side of Big Pharma?at Motley Fool (Mon, Jan 14)

Add GILD News to My Yahoo!